{"id":"W2911434758","doi":"10.1111/bjd.17628","title":"Efficacy and safety of mirikizumab ( <scp>LY</scp> 3074828) in the treatment of moderate‐to‐severe plaque psoriasis: results from a randomized phase <scp>II</scp> study","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":76,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Innovaderm (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Placebo; Psoriasis Area and Severity Index; Psoriasis; Adverse effect; Internal medicine; Clinical endpoint; Gastroenterology; Plaque psoriasis; Randomized controlled trial; Surgery; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007090449,0.0003817375,0.00235394,0.0003398173,0.0001622359,0.00002784431,0.0004333377,0.0003968812,0.00001862936],"category_scores_gemma":[0.0008035417,0.0002970214,0.0003689465,0.0002670843,0.0002405814,0.0001450802,0.00007260936,0.0003066115,0.00002380798],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005823306,"about_ca_system_score_gemma":0.0001873122,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00053753,"about_ca_topic_score_gemma":0.0002931383,"domain_scores_codex":[0.9946905,0.002370904,0.001887611,0.0004312272,0.0001425476,0.000477151],"domain_scores_gemma":[0.9928055,0.005386378,0.001124118,0.0003952149,0.000215473,0.0000732663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5325764,0.06019588,0.02206361,0.0001968173,0.02572311,0.01017065,0.1707659,0.0004015397,0.03177739,0.0003590756,0.01524444,0.1305251],"study_design_scores_gemma":[0.8994484,0.004980639,0.02709829,0.0004450568,0.001736299,0.0156644,0.009681265,0.00001688406,0.03535001,0.0002672169,0.005163937,0.0001475997],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9792091,0.01720552,0.0000280232,0.0001974647,0.0006398617,0.001832741,0.0005234356,0.0000130706,0.0003507897],"genre_scores_gemma":[0.9946442,0.004643076,0.0001579171,0.0000594458,0.00004899906,0.00005378628,0.0001168729,0.00002645228,0.000249236],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.366872,"threshold_uncertainty_score":0.9999482,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01353701810919208,"score_gpt":0.251430133745222,"score_spread":0.2378931156360299,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}